{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:03:10Z","timestamp":1760238190287,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The current Covid-19 pandemic has pointed out some major deficiencies of the even most advanced societies to fight against viral RNA infections. Once more, it has been demonstrated that there is a lack of efficient drugs to control RNA viruses. Aptamers are efficient ligands of a great variety of molecules including proteins and nucleic acids. Their specificity and mechanism of action make them very promising molecules for interfering with the function encoded in viral RNA genomes. RNA viruses store essential information in conserved structural genomic RNA elements that promote important steps for the consecution of the infective cycle. This work describes two well documented examples of RNA aptamers with antiviral activity against highly conserved structural domains of the HIV-1 and HCV RNA genome, respectively, performed in our laboratory. They are two good examples that illustrate the potential of the aptamers to fill the therapeutic gaps in the fight against RNA viruses.<\/jats:p>","DOI":"10.3390\/ph13080157","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T05:10:30Z","timestamp":1595394630000},"page":"157","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-7973","authenticated-orcid":false,"given":"Alfredo","family":"Berzal-Herranz","sequence":"first","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina L\u00f3pez-Neyra, (IPBLN-CSIC), Av. del Conocimiento 17, PTS Granada, Armilla, 18016 Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Romero-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Instituto de Parasitolog\u00eda y Biomedicina L\u00f3pez-Neyra, (IPBLN-CSIC), Av. del Conocimiento 17, PTS Granada, Armilla, 18016 Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/rmv.1756","article-title":"Unmasking the information encoded as structural motifs of viral RNA genomes: A potential antiviral target","volume":"23","year":"2013","journal-title":"Rev. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15788","DOI":"10.1074\/jbc.M116.735613","article-title":"Structural and functional characterization of programmed ribosomal frameshift signals in west nile virus strains reveals high structural plasticity among cis-acting RNA elements","volume":"291","author":"Moomau","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17536","DOI":"10.1074\/jbc.RA118.005606","article-title":"Functional and structural characterization of the chikungunya virus translational recoding signals","volume":"293","author":"Kendra","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/355850a0","article-title":"Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures","volume":"355","author":"Ellington","year":"1992","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0022-2836(92)90870-P","article-title":"Selection of high affinity RNA ligands to the bacteriophage R17 coat protein","volume":"228","author":"Schneider","year":"1992","journal-title":"J. Mol. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev.biochem.68.1.611","article-title":"In vitro selection of functional nucleic acids","volume":"68","author":"Wilson","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00216-007-1735-8","article-title":"Selection of fluorescent aptamer beacons that light up in the presence of zinc","volume":"390","author":"Rajendran","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1002\/anie.200800216","article-title":"Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting","volume":"47","author":"Raddatz","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/j.bios.2008.11.010","article-title":"Aptasensors for detection of microbial and viral pathogens","volume":"24","author":"Alocilja","year":"2009","journal-title":"Biosens. Bioelectron."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.3390\/molecules15074610","article-title":"In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules","volume":"15","author":"Marton","year":"2010","journal-title":"Molecules"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.3390\/s150716281","article-title":"Nucleic acid aptamers: An emerging tool for biotechnology and biomedical sensing","volume":"15","author":"Ku","year":"2015","journal-title":"Sensors"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kumar, P.K. (2016). Monitoring intact viruses using aptamers. Biosensors, 6.","DOI":"10.3390\/bios6030040"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1348.062","article-title":"Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases","volume":"1082","author":"Ng","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/ICU.0b013e32832d25b3","article-title":"Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration","volume":"20","author":"Ciulla","year":"2009","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00216-006-0826-2","article-title":"Methods developed for SELEX","volume":"387","author":"Gopinath","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.bios.2004.11.006","article-title":"Analytical applications of aptamers","volume":"20","author":"Tombelli","year":"2005","journal-title":"Biosens. Bioelectron."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Odeh, F., Nsairat, H., Alshaer, W., Ismail, M.A., Esawi, E., Qaqish, B., Bawab, A.A., and Ismail, S.I. (2019). Aptamers chemistry: Chemical modifications and conjugation strategies. Molecules, 25.","DOI":"10.3390\/molecules25010003"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Berzal-Herranz, A., and Romero-Lopez, C. (2020, July 22). RNA Aptamers: Antiviral Drugs of the Future. In Proceedings of the 5th International Electronic Conference in Medicinal Chemistry, MDPI AG: Sciforum. Available online: https:\/\/ecmc2019.sciforum.net\/.","DOI":"10.3390\/ECMC2019-06415"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0003-2697(89)90207-8","article-title":"Degree of biotinylation in nucleic acids estimated by a gel retardation assay","volume":"179","author":"Theissen","year":"1989","journal-title":"Anal. Biochem."},{"key":"ref_23","first-page":"183","article-title":"Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method","volume":"386","year":"2005","journal-title":"Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/ph5010049","article-title":"Anti-HCV RNA aptamers targeting the genomic cis-acting replication element","volume":"5","author":"Marton","year":"2012","journal-title":"Pharmaceuticals"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1038\/srep06242","article-title":"Efficient HIV-1 inhibition by a 16 nt-long RNA aptamer designed by combining in vitro selection and in silico optimisation strategies","volume":"4","author":"Stich","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4161\/rna.8.2.14801","article-title":"HIV-1 as RNA evolution machine","volume":"8","author":"Berkhout","year":"2011","journal-title":"RNA Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Berzal-Herranz, A., Romero-L\u00f3pez, C., Berzal-Herranz, B., and Ramos-Lorente, S. (2019). Potential of the other genetic information coded by the viral RNA genomes as antiviral target. Pharmaceuticals, 12.","DOI":"10.3390\/ph12010038"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Romero-L\u00f3pez, C., and Berzal-Herranz, A. (2020). The role of the RNA-RNA interactome in the hepatitis C virus life cycle. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041479"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3389\/fmicb.2017.02093","article-title":"The 5BSL3.2 functional RNA domain connects distant regions in the hepatitis C virus genome","volume":"8","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.3390\/molecules200916030","article-title":"RNA aptamers as molecular tools to study the functionality of the hepatitis C virus CRE region","volume":"20","year":"2015","journal-title":"Molecules"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2893.2012.01629.x","article-title":"RNA aptamer-mediated interference of HCV replication by targeting the CRE-5BSL3.2 domain","volume":"20","author":"Marton","year":"2013","journal-title":"J. Viral Hepat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1007\/s00018-007-7345-y","article-title":"Inhibition of hepatitis C virus internal ribosome entry site-mediated translation by an RNA targeting the conserved IIIf domain","volume":"64","year":"2007","journal-title":"Cell Mol. Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1099\/vir.0.008821-0","article-title":"Inhibition of hepatitis C virus replication and internal ribosome entry site-dependent translation by an RNA molecule","volume":"90","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2012.02.015","article-title":"An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication","volume":"94","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Romero-L\u00f3pez, C., Lahlali, T., Berzal-Herranz, B., and Berzal-Herranz, A. (2017). Development of optimized inhibitor RNAs allowing multisite-targeting of the HCV genome. Molecules, 22.","DOI":"10.3390\/molecules22050861"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/13\/8\/157\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:50:33Z","timestamp":1760176233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/13\/8\/157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["ph13080157"],"URL":"https:\/\/doi.org\/10.3390\/ph13080157","relation":{},"ISSN":["1424-8247"],"issn-type":[{"type":"electronic","value":"1424-8247"}],"subject":[],"published":{"date-parts":[[2020,7,22]]}}}